Dalpiciclib + Fulvestrant in Relapsed or Progressed HR+/HER2- Breast Cancer. (5th August 2021)

Record Type:: Journal Article
Title:: Dalpiciclib + Fulvestrant in Relapsed or Progressed HR+/HER2- Breast Cancer. (5th August 2021)
Main Title:: Dalpiciclib + Fulvestrant in Relapsed or Progressed HR+/HER2- Breast Cancer
Authors:: Wiley, Frieda
Abstract:
Is Part Of:: Oncology times. Volume 43:Supplement S15(2021)
Journal:: Oncology times
Issue:: Volume 43:Supplement S15(2021)
Issue Display:: Volume 43, Issue 15 (2021)
Year:: 2021
Volume:: 43
Issue:: 15
Issue Sort Value:: 2021-0043-0015-0000
Page Start:
Page End:
Publication Date:: 2021-08-05
Subjects:: Oncology -- Periodicals
Cancer -- Periodicals
Cancer
Oncology
Periodicals
616.944
Journal URLs:: http://www.oncology-times.com/ ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/01.COT.0000771944.33975.d6 ↗
Languages:: English
ISSNs:: 0276-2234
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6256.984000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19919.xml